In 1970, when reviewing the results of secretinpancreozymin tests done in Manchester Royal Infirmary (Burton, Evans, Harper, Howat, Oleesky, Scott, and Varley, 1960) , it was apparent that the mean volume of duodenal contents after secretin had fallen. Since the technique had varied little over the years the possibility of deterioration in the secretin used was considered. We have learned from Mr Birkenshaw, Head of Bioassay of The Boots Company Ltd, (Birkenshaw, 1974, personal com- (Crick, Harper, and Raper, 1949) glass ampoule contained 75 clinical units (CU) of highly purified secretin to which is added 1 mg of cysteine hydrochloride to preserve activity (Jorpes and Mutt, 1973) . Boots secretin was stored at 40C
and GIH secretin at -20°C. Immediately before use both preparations were dissolved in sterile normal saline at room temperature to provide a concentration of 2 CHR units/ml of Boots secretin and 0 5 CU/nil of GIH secretin.
EXPERIMENTAL PROCEDURES
Four cats weighing 2-7, 2-3, 2-6, and 3 0 kg were fasted for 24 hours before the experiments, anaesthetized, and prepared according to the technique of Howat and Schofield (1954) . The splanchnic nerves were divided extraperitoneally. The pancreatic duct was cannulated, and the common bile duct obliterated by the ligature retaining the cannula. The pylorus was occluded by a broad tape ligature.
Since a preliminary experiment indicated that 1 CHR unit of Boots secretin was approximately four times less potent than one CU of GIH secretin (fig 1) , rapid intravenous injections of 1 and 2 CHR units/kg of Boots secretin and 0-25 and 0 5 CU/kg of GIH secretin were used in each cat. The order of administration of the secretins was determined by a 2 x 2 Latin square arrangement, with the restrictions of equal numbers of observations per dose, equal numbers of doses per substance, equal logarithmic spacing of the doses, and that the higher doses of the two secretins were not given consecutively.
Observations Tests of dependence, linearity, and parallelism were applied to the data for volume and bicarbonate output, and the relative potency of the CHR and the CU was estimated (Emmens, 1948) . . juice or bicarbonate output in each instance. A * four-point assay was therefore used (Emmens, 1948 (Harper and Vass, 1941) . Although anaesthesia itself may contribute to the variation in responses (Crick et al, 1949) , the advantages of pyloric and bile duct occlusion which prevents the release of either stimulating or inhibiting duodenal hormones outweigh this consideration.
Hammerstein, Wilander, and Agren (1928) based their secretin assay on the amount of alkali produced in cats, whereas the Ivy group measured the volume of secretion in dogs. Harper (1967) has shown that in cats when rates of flow exceed a minimum level of 10 ml/10 min in response to a single intravenous injection of secretin the concentrations of bicarbonate and chloride are constant at about 140 and 24 mM per litre respectively, but that at lower rates of flow the bicarbonate concentration decreases and the chloride increases in inverse fashion due to exchange of these ions within the duct, the sum of the two remaining constant. A comparison of bicarbonate outputs when the volume is less than 1 ml/10 min may therefore be a less reliable index than rates of flow, since in these circumstances small differences in the volume of pancreatic juice may be associated with relatively large differences in bicarbonate concentration and output.
Lagerlof (1942) (Jorpes and Mutt, 1973) , so that 'the current clinical unit probably equals that of the old Pancreotest (Astra) unit with which Lagerlof (1942) elaborated the secretin test of pancreatic function' (Zimmerman, Dreiling, and Janowitz, 1973) . Crick et al (1949) defined their unit of secretin as the activity present in 01 mgofan arbitbrarily chosen standard preparation which yielded a mean of 1 2 ml in 12 min; Jorpes and Mutt (1966) .unit/kg of Pancreotest (Astra) in man produced an average of 135 ml ofjuice in 30 minutes (Lagerlof, 1942) while 1-7 CHR units/kg of Boots secretin produced 136 ± 6-2 ml (mean ± SE of mean) in 30 minutes (Burton et al, 1960) . Thus 1 CHR unit equals 0 58 clinical units of Pancreotest, justifying the conclusion of Jorpes and Mutt (1966) .
The relatively greater potency of the unit of GIH secretin when compared with the unit of Boots secretin in terms of bicarbonate, 3 96:1, than in terms of volume 3-76:1, cannot be explained by an increased amount of pancreozymin in Boots secretin (Harper, 1967) . In our experiments the concentra-tions of chloride and lipase in response to 1 CHR u/kg Boots secretin do not differ from those obtained in response to 0-25 CU/kg GIH secretin nor do they differ in response to 2 CHR u/kg Boots secretin and 0 5 CU/kg GIH secretin (t = 0-7 < p < 0-8 in each case). In one experiment the mean peak concentration of lipase in response to 4 CHR u/kg/hr Boots secretin was 9 35 IU/ml and in response to 1 CU/kg/ hr GIH secretin was 10-35 IU/ml, the chloride concentration being 30 mM and 38 mM/litre respectively. We conclude therefore that neither of the batches of secretin used in these experiments contained a significant quantity of cholecystokininpancreozymin.
Reports that 1 CHR unit of Boots secretin was nine to 10 times less potent than 1 CU of GIH secretin in stimulating the pancreas in cats (Konturek, 1969) , dogs (Stening, Vagne, and Grossman, 1968) , and man (Vagne, Descos, and Martin, 1969) were therefore unexpected. We have been informed that the Boots preparation during the period of these reports fell below standard. Our experiments in cats show that the revised clinical unit of GIH secretin is four times more potent than the restandardized CHR unit of Boots secretin. This may mean that the fourfold increase in strength applied by Jorpes and Mutt to GIH secretin has yielded a clinical unit approximately twice as potent as the original clinical unit of Pancreotest (Lagerlof, 1942) .
From our data in cats (fig 1) 
